Toll/interleukin-1 receptor (TIR) domain-containing proteins have NAD-RNA decapping activity

Xufeng Wang,Dongli Yu,Jiancheng Yu,Hao Hu,Runlai Hang,Zachary Amador,Qi Chen,Jijie Chai,Xuemei Chen
DOI: https://doi.org/10.1038/s41467-024-46499-y
IF: 16.6
2024-03-13
Nature Communications
Abstract:Abstract The occurrence of NAD + as a non-canonical RNA cap has been demonstrated in diverse organisms. TIR domain-containing proteins present in all kingdoms of life act in defense responses and can have NADase activity that hydrolyzes NAD + . Here, we show that TIR domain-containing proteins from several bacterial and one archaeal species can remove the NAM moiety from NAD-capped RNAs (NAD-RNAs). We demonstrate that the deNAMing activity of AbTir (from Acinetobacter baumannii ) on NAD-RNA specifically produces a cyclic ADPR-RNA, which can be further decapped in vitro by known decapping enzymes. Heterologous expression of the wild-type but not a catalytic mutant AbTir in E. coli suppressed cell propagation and reduced the levels of NAD-RNAs from a subset of genes before cellular NAD + levels are impacted. Collectively, the in vitro and in vivo analyses demonstrate that TIR domain-containing proteins can function as a deNAMing enzyme of NAD-RNAs, raising the possibility of TIR domain proteins acting in gene expression regulation.
multidisciplinary sciences
What problem does this paper attempt to address?